Enovis to Acquire eCential Robotics for €155M Enterprise Value, Adding Surgical Robotics to ASTRA Platform
ENOV sits 28% above its 52-week low of $19.14.
Summary
Enovis announced a binding offer to acquire eCential Robotics for €155M upfront enterprise value (€176M cash at closing plus up to €35M in milestones), adding surgical robotics to its ASTRA platform. The deal is expected to close by year-end 2026 and will temporarily pressure margins before improving in 2028.
Key Events · M&A and Partnerships · ENOV
-
Binding Offer to Acquire eCential Robotics
Enovis entered into a binding offer to acquire eCential Robotics SAS, a developer of surgical robotics and enabling technologies, for an upfront enterprise value of €155 million.
-
Deal Consideration and Milestones
Cash consideration of approximately €176 million will be paid to eCential shareholders at closing, with up to an additional €35 million in contingent milestone payments.
-
Strategic Expansion of ASTRA Platform
The acquisition adds robotic automation capabilities to Enovis' ASTRA enabling technology ecosystem, complementing the ARVIS augmented reality system and creating a robotics center of excellence in Grenoble, France.
-
Financial Impact and Guidance
Management expects approximately 150 basis points of deal-related adjusted EBITDA margin dilution in 2027, partially offset by 50 basis points of underlying improvement, resulting in a net 100 basis point headwind before returning to margin improvement in 2028.
Analysis · ENOV · Industrial Applications And Services
Enovis is acquiring eCential Robotics, a French surgical robotics developer, for €155 million upfront enterprise value — approximately €176 million in cash at closing plus up to €35 million in milestone payments. The deal expands Enovis' ASTRA enabling technology platform into robotic automation, complementing its ARVIS augmented reality system. Management expects the acquisition to dilute adjusted EBITDA margins by roughly 100 basis points in 2027 before returning to year-over-year margin improvement in 2028, while free cash flow conversion is projected to rise to 50% in 2027. The transaction is expected to close by year-end 2026, subject to regulatory approvals and French works council consultation.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ENOV was trading at $24.59 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $19.14 to $34.28. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.